Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef5fb4e7dc046fc97865f350bf557b53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bed36a05d84c501861ea7cf06c5d146e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1035fb49d1353d38698731623e40d9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b107d51917600dfc9b98575c434ccea |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate |
2005-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aeeb2c495de3f1388bad839fb8d1164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_223cbccafaff9bd2f89ca4cd6553576f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6227e659dd8e9925cd762ad1aa611792 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fc8585a63d10bb00c8257b732f41848 |
publicationDate |
2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006111334-A1 |
titleOfInvention |
Oral solid dosage forms containing a low dose of estradiol |
abstract |
The present invention relates to oral solid dosage forms containing a very low dose of estradiol. The dosage forms are formulated in a manner so as to avoid degradation of the estradiol and to minimise the content of polyvinylpyrrolidone, while still achieving similar fast dissolution of the estradiol. The dosage forms are useful in preventing or treating a physical condition in a woman caused by insufficient endogenous levels of estradiol. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019152798-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013140210-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013178452-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11617751-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266649-B2 |
priorityDate |
2004-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |